LIC announced on Thursday that it had sold 2 percent of its stake in Sun Pharma for Rs 4,699 crore in an open market transaction.
Following the share sale, there is a decrease of 2 percent decline in holding between July 22, 2022, and September 13, 2023.
In a regulatory filing, LIC stated, “Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 percent to 3.012 percent of the paid-up capital of the said company”.
“The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction”, LIC added.
Sun Pharma manufactures, develops, and markets a diverse range of branded and generic formulations, as well as Active Pharma Ingredients (APIs).
LIC, the country’s largest state-owned insurer, finished at Rs 660.80 per share on BSE, up 0.27 percent. Sun Pharma shares closed 0.8 percent higher at Rs 1,143.60.
Also read: Maruti Suzuki Collaborates With Indian Bank To Offer Dealers Financing Options
CM Yogi Adityanath's government has approved key connectivity projects to boost Uttar Pradesh's infrastructure for…
Several passengers were reportedly killed, and 30-40 others injured when passengers of the Pushpak Express,…
Under CM Yogi, Prayagraj has become a city of temples, offering pilgrims replicas of India's…
During Maha Kumbh, CM Yogi Adityanath's Cabinet approved transformative projects for Uttar Pradesh's development.
The Maharashtra government and Reliance Industries signed a monumental MoU worth ₹3.05 lakh crore at…
In a Cabinet meeting chaired by CM Yogi Adityanath, the UP govt approved 10 major…